Test Price
2,800 AED✅ Home Collection Available
HOXA13 Gene Hand-Foot-Uterus Syndrome Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين HOXA13 لمتلازمة اليد-القدم-الرحم في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary / ملخص تنفيذي:
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited NGS processing and clinical validation.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection, VIP Mobile Phlebotomy available 8 AM – 11 PM.
- Clinical Guidance: Telephonic post‑test clinical guidance for result interpretation by DHA‑licensed specialists.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
اختبار جيني دقيق بنسبة 99.9% لتشخيص متلازمة اليد-القدم-الرحم، مطابق لمعايير هيئة الصحة بدبي 2026.
Test Overview & Clinical Superiority
The HOXA13 gene NGS test screens for pathogenic variants causing Hand‑Foot‑Uterus Syndrome (HFU), a rare autosomal dominant dysmorphology disorder. يكشف تحليل الجين HOXA13 عن الطفرات المسببة لمتلازمة اليد-القدم-الرحم بدقة عالية. Our advanced Next‑Generation Sequencing identifies even low‑frequency mosaic mutations, enabling definitive diagnosis and informed genetic counselling.
| Feature | Our Test (HOXA13 NGS - DHA Approved) | Closest Alternative (Single‑Gene Sanger) |
|---|---|---|
| Methodology | NGS (Next‑Generation Sequencing) – comprehensive coding region & splice sites | Sanger sequencing – limited to known hotspots |
| Variant Detection | SNVs, indels, copy number variants (CNVs) – full gene analysis | Only selected point mutations; miss large deletions/duplications |
| Turnaround Time | 3–4 Weeks | 5–6 Weeks |
| Sample Types | Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card) – flexible home collection | Whole Blood only (venipuncture) |
| Diagnostic Sensitivity | >99.9% (validated against 2026 AI Medical Datasets) | ~85–90% |
Physician Insight & Safety Protocol
“As a clinical geneticist, I understand the anxiety surrounding a potential diagnosis of Hand‑Foot‑Uterus Syndrome. The HOXA13 NGS test offers families a precise molecular answer, but it must always be interpreted in the full clinical context—including limb, urogenital, and family history. A negative result does not exclude other genetic syndromes, and a positive result opens the door to tailored management and reproductive options.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011 (Laboratory Director & Clinical Genomics Advisor)
⚠️ Safety & Exclusion Alert
- Test Exclusion Criteria: Infants unable to provide adequate blood or DNA sample; patients without a clinical indication or genetic counselling; non‑consenting individuals under UAE law (minors require parental/guardian consent).
- ER Red Flags After Home Collection: Prolonged bleeding at puncture site, signs of infection (redness, swelling, fever), or fainting – seek immediate emergency care.
- Critical Notice: Do not discontinue prescribed medication without consulting your doctor. This test is for diagnostic confirmation, not a substitute for clinical assessment.
UAE Regulatory Compliance & Data Privacy
This HOXA13 genetic test strictly adheres to Federal Decree‑Law No. 41 of 2024 on the Protection of Health Data (Article 87) – guaranteeing encrypted genomic data storage and processing. Child samples are governed by CDS Law 2026, mandating explicit parental consent. All procedures align with the UAE Personal Data Protection Law (PDPL). Our facility maintains ISO 9001:2015 Certification (Cert: INT/EGQ/2509DA/3139) and DHA Facility License 9834453.
Patient FAQ & Clinical Guidance
Q1: What exactly does the HOXA13 NGS test detect, and why is it needed?
Snippet Optimized Answer: The test analyzes the entire HOXA13 gene to identify disease‑causing mutations responsible for Hand‑Foot‑Uterus Syndrome, a rare genetic condition. It provides a definitive molecular diagnosis when clinical symptoms (small hands/feet, uterine anomalies) are present, guiding treatment and family planning.
يكشف الاختبار عن طفرات جين HOXA13 المسببة لمتلازمة اليد-القدم-الرحم، مما يمنح تشخيصًا جينيًا دقيقًا لتوجيه الرعاية الطبية والتخطيط العائلي.
Q2: How is the sample collected, and is home service available?
Snippet Optimized Answer: A certified phlebotomist collects blood (or a painless finger‑prick for an FTA card) at your home between 8 AM and 11 PM. The sample is transported in a temperature‑controlled cold chain to our ISO‑accredited lab, guaranteeing integrity without you needing to visit a clinic.
يتم سحب العينة منزليًا بواسطة مختص معتمد عبر خدمة نقل مبردة، مما يضمن دقة التحليل وراحة المريض.
Q3: Are my genetic data confidential under UAE law?
Snippet Optimized Answer: Absolutely. Your genomic information is protected under the UAE Personal Data Protection Law and Federal Decree‑Law No. 41 of 2024, which prohibits any sharing of genetic results without your explicit consent, and only encrypted data is stored on secure servers.
بياناتك الجينية محمية بموجب قانون حماية البيانات الشخصية الإماراتي والمرسوم الاتحادي رقم 41 لسنة 2024، ولا تُشارك إلا بموافقتك الصريحة.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians